Stem cells could offer hope for muscular dystrophy

Stem cells could offer hope for muscular dystrophy

Muscular dystrophies are genetic conditions that cause muscles to become progressively weaker. Researchers are investigating several novel approaches, including gene and stem cell therapy, to meet the challenges of these serious illnesses. Recently, Dr Yoshitsugu Aoki of the National Center of Neurology and Psychiatry, Tokyo and colleagues have drawn on research from around the world to create a picture of […]

Read More…

A new academic discipline: Advancing factory science, economics and artifacts science

A new academic discipline

Professor Masayuki Matsui from The University of Electro-Communications, Tokyo, proposes that Industrial Engineering and Operational Research (IEOR) can be viewed as the art of his 3M&I-body system. His methods have led to a new academic discipline that contribute to the integration of knowledge and intelligence in nature versus artifacts science. This research facilitates the realisation of the cyber/real world, including […]

Read More…

Understanding the EGFR mutation
aids the fight against lung cancer

Dr Yamaoka studies the mechanisms of drug resistance in lung cancer patients.

Genetic mutations are known to be responsible for several different types of cancer. One type, known as non-small cell lung cancer, is sometimes caused by mutations in a gene called EGFR. A group of drugs called tyrosine kinase inhibitors are often used to treat patients with this type of cancer. Unfortunately, patients can develop genetic alterations, namely mutation, amplification (an […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION